Clinical Trials Directory

Trials / Unknown

UnknownNCT04961502

Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Gérond'if · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main objective of this study is to describe the humoral and cellular response to BNT162b2 vaccination in people over age 75 institutionalized in the long-term care units of the Paris Public Hospitals (APHP)

Detailed description

This is an interventional study with minimal risk and constraints, multicenter with biological collection. Two populations are studied: patients and members of care staff. The following data will be collected: * For patients and staff: age, gender, existence of Coronavirus Disease 2019 (COVID-19) infection and whether or not it is symptomatic and date of first positive RT-PCR test, medical history * For patients: nutritional status (loss of appetite, weight loss, body mass index, albuminemia) Vaccination antibodies are measured using 3 blood sample: The first carried out before the anti-Coronavirus Disease 2019 (COVID-19) vaccination; the second on D21 (shortly before the vaccination booster injection) and the third on D50-54. In addition, during the first sample, assays will be carried out informing us of your nutritional and inflammatory status.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood test to describe the humoral and cellular response to vaccination BNT162b2 in the elderly3 blood samples taken to compare the immunization response of the elderly with that of younger adults (priority caregivers): the first carried out before the anti-Coronavirus Disease 2019 (COVID-19) vaccination; the second shortly before the vaccination booster injection and the third approximately two months after the first vaccine injection

Timeline

Start date
2021-03-11
Primary completion
2021-08-01
Completion
2021-09-01
First posted
2021-07-14
Last updated
2021-07-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04961502. Inclusion in this directory is not an endorsement.